TREATMENT TABLES Flashcards
1
Q
PRURIGO NODULARIS AND LICHEN SIMPLEX CHRONICUS
A
2
Q
Treatment Options for Pityriasis Rubra Pilaris
A
3
Q
Treatment of Large-Plaque Parapsoriasis and Small-Plaque Parapsoriasis
A
4
Q
Treatment of Pityriasis Lichenoides et Varioliformis Acuta and Pityriasis Lichenoides Chronica
A
5
Q
Treatment of Lichen Nitidus
A
6
Q
Treatment Options for Granuloma Annulare
A
7
Q
Sarcoid Medical Therapy
A
8
Q
Systemic Treatments for Sweet Syndrome
A
9
Q
Treatment Options for Pyoderma Gangrenosum
A
10
Q
Treatments for Subcorneal Pustular Dermatosis
A
11
Q
Treatments for Granuloma Faciale
A
12
Q
Treatment algorithm for chronic urticaria
A
13
Q
Treatment of Cutaneous Mastocytosis
A
14
Q
Treatment of Noncutaneous Mastocytosis Symptoms
A
15
Q
Therapeutic Options in the Management of Epidermal Necrolysis
A
16
Q
Darier Disease: Treatment
A
17
Q
Hailey-Hailey Disease: Treatment
A
18
Q
Treatment for Porokeratosis
A
19
Q
Treatments for Paraneoplastic Pemphigus
A
20
Q
Treatments for Bullous Pemphigoid
A
21
Q
Treatments for Mucous Membrane Pemphigoid
A
22
Q
Treatments for Epidermolysis Bullosa Acquisita (EBA)
A
23
Q
Treatment options for LAD and CBDC
A
24
Q
Therapeutic Options for Lupus Erythematosus–Specific Skin Disease
A
25
Treatment Ladder in Dermatomyositis
26
Recommended Therapeutic Strategies for Internal Organ Involvement in Systemic Sclerosis
27
Therapeutic Options for Skin Involvement in Systemic Sclerosis
28
Therapeutic algorithm for morphea based on existing evidence
29
Morphea Therapy
30
PSORIATIC DISEASE SPECIFIC INDICATIONS
31
Summary of 2015–2016 PsA management guidelines from EULAR and GRAPPA
32
Management of Sicca Symptoms in Sjögren Syndrome
33
Treatment of Acquired Perforating Dermatosis
34
Treatment Algorithm for Acne Vulgaris
35
Symptom manifestation-dependent therapy regimen in rosacea
36
Physical Interventions in Rosacea Therapy
37
Treatment of Ocular Rosacea
38
Select Therapeutic Strategies for Fox-Fordyce
39
Ratings of Select Therapies for Hidradenitis Suppurativa Based on Category of Evidence and Strength of Recommendation
40
Pharmacologic Treatment of Hirsutism
41
Treatment of Actinic Keratoses
42
Topical Treatments for Actinic Keratoses
43
Treatment of Bowen Disease
44
Risk Factors for the Conversion of Oral Leukoplakia into Oral Squamous Cell Carcinoma
45
Treatment Options for Patients Suffering from Single-System Langerhans Cell Histiocytosis
46
Treatment Algorithms for Mycosis Fungoides and Sézary Syndrome
47
Biologic Response Modifiers for the Treatment of Erythrodermic Cutaneous T-cell Lymphomas
48
Treatment Algorithms for Cutaneous B-Cell Lymphomas
49
Treatment of Nodular Pseudolymphoma
50
Fabry Disease
51
Other Potential Systemic Treatments of Chronic Skin Graft-Versus-Host Disease
52
Treatment of Chronic Granulomatous Disease
53
Topical Treatment of Oral Aphthous Ulcers
54
Systemic Treatments of Adamantiades–Behçet Disease
55
Other Systemic Treatments of Adamantiades-Behçet Disease
56
Treatment of Acute Kawasaki Disease
57
Pharmacologic Therapies for Raynaud Phenomenon
58
Treatment of Malignant Atrophic Papulosis (Degos Disease)
59
Treatment of Obstructive Peripheral Arterial Disease
60
Treatment of Thromboangiitis Obliterans
61
Treatment of Chronic Venous Insufficiency
62
Therapeutic Options for lymphedema
63
Management of Staphylococcus aureus Skin Infections
64
Management of Skin Infections Caused by Group A Streptococcus
65
Bacterial Cellulitis
66
Infectious Diseases Society of America 2014 Guidelines for Antimicrobial Management for Patients with Necrotizing Soft-Tissue Infections
67
Therapy Guidelines for Mycobacterium Tuberculosis Infections
68
Lepra Reactions and Management
69
Antibacterial Treatment of Leprosy Recommendations
70
Treatment of Dermatophytes
71
Oral Antifungal Agents
72
Topical Antifungal Agents
73
Candidiasis Treatment Algorithm
74
Treatment Algorithm for Cutaneous Malassezia Infections
75
Summary of Subcutaneous Mycoses
76
Treatments for Measles
77
Treatments for Parvovirus B19 Infections
78
Treatment for Epstein-Barr Virus Infectious Mononucleosis
79
Recommended Regimens for the Treatment of Orofacial Herpes Simplex Infections
80
Recommended Regimens for the Treatment of Genital Herpes Simplex Infections
81
Recommended Regimens for Other Herpes Cutaneous Diseases
82
Antiviral Treatment of Varicella in the Normal and Immunocompromised Host
83
Antiviral Treatment of Herpes Zoster in the Normal and Immunocompromised Host
84
Recommendations for the Use of Herpes Zoster Vaccines (2018 ACIP Recommendations)
85
Vaccination Against Smallpox Using Vaccinia Virus
86
Commonly Used Treatments for Cutaneous and Anogenital Warts
87
Centers for Disease Control and Prevention Recommendations for Treatment and Followup of Adults with Primary, Secondary, Early Latent, or Late Latent Syphilis.
88
Treatment options for Chancroid
89
Treatment of Lymphogranuloma Venereum
90
Treatment of Granuloma Inguinale
91
Prophylaxis for Gonococcal Infection in Neonates
92
Treatment of Localized, Uncomplicated Gonococcal Infection of the Cervix, Rectum, Pharynx, or Urethra (2015 CDC Guidelines)
93
Treatment of Disseminated Gonococcal Infection
94
Treatment of Gonococcal Infection in Neonates
95
Treatment of Mycoplasma Urethritis
96
Treatment of Chlamydia Infection
97
Treatment of Bacterial Vaginosis
98
Local Therapy Against Cutaneous Leishmaniasis
99
Systemic Drugs Available Against Leishmaniasis
100
Systemic Treatment Recommendations for Leishmaniasis
101
Treatment Options against African Trypanosomiasis
102
Treatment of Selected Helminthic Infections Causing Cutaneous Diseases
103
Treatment of Scabies
104
Treatment of Head Lice and Crab Lice
